title: Effect of terfenadine in asthmatic patients.
abstract: The bronchodilator effect of terfenadine, 60-mg or 120-mg single dose, and 1 week twice daily dosing, was evaluated in 12 allergic asthmatic patients. When compared with baseline, FEV1 rose significantly for single dose 120 mg terfenadine at one, one and one-half, three, five and one-half, and six hours and for 60 mg terfenadine at three, five and one-half, six, and eight hours postdose. Variations in patient response were observed. At steady state, 120 mg terfenadine b.i.d. showed consistent improvement over placebo from three to 12 hours postdosing but no improvement in FEV1 was noted for terfenadine, 60 mg b.i.d. There no longer was a statistically significant difference in mean FEV1 or percent change from baseline. Thus, terfenadine proved to be a safe and a mild bronchodilator; however, tachyphylaxis might develop to the bronchodilator effect after 1 week of continuous b.i.d. dosing.
authors.affiliation: Department of Medicine, UCLA School of Medicine.
authors.forename: S
authors.initials: S
authors.lastname: Spector
authors.forename: N
authors.initials: N
authors.lastname: Lee
authors.forename: B
authors.initials: B
authors.lastname: McNutt
authors.forename: R M
authors.initials: RM
authors.lastname: Katz
authors.forename: W
authors.initials: W
authors.lastname: Huster
authors.forename: S
authors.initials: S
authors.lastname: Siegel
authors.forename: G
authors.initials: G
authors.lastname: Rachelefsky
authors.forename: A
authors.initials: A
authors.lastname: Rohr
mesh_terms: D001249:Asthma / Q000188:drug therapy*; D004311:Double-Blind Method; D005541:Forced Expiratory Volume; D006801:Humans; D016593:Terfenadine / Q000627:therapeutic use*
chemical_list: D016593:Terfenadine